In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of Leishmania major infection: Powerful synergistic and multifunctional effects.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 19 07 2021
revised: 11 10 2021
accepted: 12 10 2021
pubmed: 24 10 2021
medline: 25 3 2022
entrez: 23 10 2021
Statut: ppublish

Résumé

The ongoing conventional drugs for leishmaniasis treatment are insufficient. The present study aimed to assess 6-gingerol alone and in combination with amphotericin B on Leishmania major stages using experimental and in vivo murine models. Here, arrays of experimental approaches were designed to monitor and evaluate the 6-gingerol potential therapeutic outcomes. The binding affinity of 6-gingerol and IFN-γ was the basis for docking conformations. 6-Gingerol combined with amphotericin B represented a safe mixture, extremely leishmanicidal, a potent antioxidant, induced a remarkable apoptotic index, significantly increased the expression of the Th1-related cytokines (IL-12p40, IFN-γ, and TNF- α), iNOS, and transcription factors (STAT1, c-Fos, and Elk-1). In contrast, the expression of the Th2-related cytokines was significantly downregulated (p < 0.001). This combination was also potent when the lesion appearance was evaluated following three weeks of treatment. The histopathological and immunohistochemical patterns of the murine model represented clusters of CD4

Identifiants

pubmed: 34688150
pii: S1567-5769(21)00910-3
doi: 10.1016/j.intimp.2021.108274
pii:
doi:

Substances chimiques

Catechols 0
Cytokines 0
Fatty Alcohols 0
STAT1 Transcription Factor 0
Amphotericin B 7XU7A7DROE
gingerol 925QK2Z900

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108274

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Alireza Keyhani (A)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Iraj Sharifi (I)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: iraj.sharifi@yahoo.com.

Ehsan Salarkia (E)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Ahmad Khosravi (A)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Razieh Tavakoli Oliaee (R)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Zahra Babaei (Z)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Pooya Ghasemi Nejad Almani (P)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Saeid Hassanzadeh (S)

Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran.

Reza Kheirandish (R)

Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran.

Mashid Mostafavi (M)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Maryam Hakimi Parizi (M)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Sodabeh Alahdin (S)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Fatemeh Sharifi (F)

Research Center for Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran.

Shahriar Dabiri (S)

Department of Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Simin Shamsi Meymandi (S)

Department of Dermatology, Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Ali Khamesipour (A)

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

Abdollah Jafarzadeh (A)

Department of Immunology, Medical School, Kerman University of Medical Sciences, Kerman, Iran.

Mehdi Bamorovat (M)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH